Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Net Margin data on record, last reported at 224.65% in Q4 2025.

  • For Q4 2025, Net Margin rose 21760.0% year-over-year to 224.65%; the TTM value through Dec 2025 reached 77.89%, up 7730.0%, while the annual FY2025 figure was 16.95%, 1619.0% up from the prior year.
  • Net Margin reached 224.65% in Q4 2025 per INDV's latest filing, up from 13.38% in the prior quarter.
  • Across five years, Net Margin topped out at 224.65% in Q4 2025 and bottomed at 32.78% in Q2 2024.